Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Boxer

Showing results (171-180 of 300) with videos related to

Pageof 30
Sort By:
Molecular Neurodegeneration|August 10, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseasesJason A Chen, Zhongbo Chen, Hyejung Won, et al.
Neurology|February 18, 2018
Early vs late age at onset frontotemporal dementia and frontotemporal lobar degenerationSang Won Seo, Marie-Pierre Thibodeau, David C Perry, et al.
Brain : a Journal of Neurology|October 3, 2014
Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansionSuzee E Lee, Anna M Khazenzon, Andrew J Trujillo, et al.
Neurology|October 16, 2016
Progression of brain atrophy in PSP and CBS over 6 months and 1 yearShubir Dutt, Richard J Binney, Hilary W Heuer, et al.
Nature Medicine|November 24, 2022
CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesKanta Horie, Nicolas R Barthélemy, Salvatore Spina, et al.
The Lancet. Neurology|May 25, 2019
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trialAdam L Boxer, Irfan Qureshi, Michael Ahlijanian, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Rates of lobar atrophy in asymptomatic <i>MAPT</i> mutation carriersQin Chen, Bradley F Boeve, Matthew Senjem, et al.
Brain : a Journal of Neurology|November 3, 2020
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseasesDavid N Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, et al.
Alzheimer'S Research & Therapy|February 2, 2019
<sup>18</sup>F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesRichard M Tsai, Alexandre Bejanin, Orit Lesman-Segev, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Longitudinal functional network connectivity changes across the clinical stages of <i>C9orf72</i> hexanucleotide repeat expansion carriersLiwen Zhang, Suvi Häkkinen, Youjin Jung, et al.
Pageof 30

Showing results (171-180 of 300) with videos related to

Sort By:
Pageof 30
Molecular Neurodegeneration|August 10, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseasesJason A Chen, Zhongbo Chen, Hyejung Won, et al.
Neurology|February 18, 2018
Early vs late age at onset frontotemporal dementia and frontotemporal lobar degenerationSang Won Seo, Marie-Pierre Thibodeau, David C Perry, et al.
Brain : a Journal of Neurology|October 3, 2014
Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansionSuzee E Lee, Anna M Khazenzon, Andrew J Trujillo, et al.
Neurology|October 16, 2016
Progression of brain atrophy in PSP and CBS over 6 months and 1 yearShubir Dutt, Richard J Binney, Hilary W Heuer, et al.
Nature Medicine|November 24, 2022
CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesKanta Horie, Nicolas R Barthélemy, Salvatore Spina, et al.
The Lancet. Neurology|May 25, 2019
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trialAdam L Boxer, Irfan Qureshi, Michael Ahlijanian, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Rates of lobar atrophy in asymptomatic <i>MAPT</i> mutation carriersQin Chen, Bradley F Boeve, Matthew Senjem, et al.
Brain : a Journal of Neurology|November 3, 2020
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseasesDavid N Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, et al.
Alzheimer'S Research & Therapy|February 2, 2019
<sup>18</sup>F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesRichard M Tsai, Alexandre Bejanin, Orit Lesman-Segev, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Longitudinal functional network connectivity changes across the clinical stages of <i>C9orf72</i> hexanucleotide repeat expansion carriersLiwen Zhang, Suvi Häkkinen, Youjin Jung, et al.
Pageof 30